Researchers examining the intimate lives of trauma survivors have found that psychedelics have varied effects on communication and emotional connection during sexual encounters. A recent global analysis indicated that women who associated psychedelics with healing from sexual trauma reported better intimate communication than men with similar trauma histories. The findings were published in The Journal of Sex Research.
Scientists are increasingly investigating substances like psilocybin, ayahuasca, and lysergic acid diethylamide to treat mental health conditions. These specific drugs interact with the serotonin system in the brain to alter perception and emotional regulation. By disrupting rigid patterns of thought, these substances can theoretically enhance emotional openness and interpersonal awareness.
When a person ingests a psychedelic, the substance modulates connectivity between key regions of the brain. This includes areas associated with self-referential thought and deep emotional processing. By interrupting normal functional connectivity, a person’s traditional cognitive boundaries temporarily soften. This specific mental state can encourage an unexpected reappraisal of deep-seated fears and interpersonal dynamics.
Many survivors of sexual violence experience lasting disruptions to their physiological and emotional responses. This trauma can manifest as sudden distress, general physical avoidance, or intense difficulty maintaining trust in intimate settings. Because traditional therapies and pharmaceutical treatments do not work for all survivors, some individuals turn to unregulated psychedelic use to navigate these lingering barriers.
Anecdotal reports suggest that the mind-altering effects of these drugs can help individuals process difficult memories and feel more connected to their partners. Yet empirical evaluations of how these substances actually perform during sexual encounters are scarce. Mason Levey, a public health researcher at the University of Queensland, led a study to quantify these subjective experiences.
The research team wanted to compare the experiences of trauma survivors who felt psychedelics aided their recovery against those who did not share that association. They focused entirely on self-reported outcomes related to sexual communication and emotional connection. The sample came from the 2022 Global Drug Survey, an anonymous questionnaire distributed globally.
The study analyzed responses from 675 participants who reported engaging in sexual activity within four to six hours of taking a full dose of a psychedelic. The average age of the respondents was about 33 years old, and the demographic heavily skewed toward employed, white individuals. To isolate the subset of trauma survivors, the team relied on a single survey question asking if a past psychedelic experience had ever helped the user cope with sexual trauma.
Within the dataset, 110 individuals reported that psychedelics had helped them cope with such trauma. The remaining 565 participants served as the comparison group. Participants rated how their most recent psychedelic-altered sexual experience affected elements like arousal, communication, and emotional connection on a scale ranging from very negative to very positive.
To ensure statistical stability, the researchers combined the extreme ends of the rating scales to eliminate categories with very few responses. They then used regression models to identify patterns, adjusting for differences in age and gender. The analysis revealed that trauma survivors were overall less likely to report relatively improved communication during a psychedelic sexual encounter compared to the non-trauma group. While a minor subset of survivors did select the highest possible positive rating for communication, that specific numerical difference was not statistically significant.
The team found similar results regarding emotional connection across the entire dataset. Overall, trauma survivors reported marginally higher levels of emotional connection during altered sexual episodes than the comparison group. However, the exact models indicated that this overall difference was not statistically significant.
A different picture emerged when the researchers focused exclusively on the internal dynamics of the trauma survivor group. Among those participants, women were noticeably more likely than men to report that psychedelics improved their communication with their sexual partners. Women in this group were also substantially more likely to report heightened emotional connection.
The researchers noted that differences between non-binary individuals and men in the trauma survivor group were not statistically significant. This suggests that the relational benefits of these substances among trauma survivors vary heavily based on gender. The authors posit that broader social norms regarding intimacy play a role in how different people react to these chemicals. Women are frequently socialized to prioritize emotional openness, which aligns with the forms of psychological vulnerability that psychedelics typically amplify.
Conversely, men might experience different baseline expectations for physical intimacy, potentially diluting the perceived emotional boost provided by the drugs. Researchers sometimes refer to an altered state of shared insight and mutual vulnerability between partners as psychedelic intimacy. Because psychedelics induce an emotional expansion on a neurobiological level, the resulting shifts might simply map better onto the typical intimacy scripts experienced by women.
Understanding these personal boundaries is necessary for developing effective harm reduction strategies. Many people who use these substances for trauma coping do so in underground networks, far from clinical oversight. In unregulated sexual environments, psychedelics present physical and psychological risks like boundary dissolution, high suggestibility, and sudden distress.
Changes to drug regulations are shifting the landscape of mental health treatment internationally. Jurisdictions like Oregon have established regulated frameworks for psilocybin use, and Australia recently reclassified specific psychedelics to authorize psychiatric prescribing for conditions like post-traumatic stress disorder. As these therapies become more accessible, harm reduction advocates must prioritize messages acknowledging that these substances do not universally erase interpersonal trauma barriers.
The researchers outlined several limitations regarding their dataset. Because the study represents a single snapshot in time, the cross-sectional design cannot prove that the drugs physically caused the reported changes in intimacy. The survey relied heavily on retrospective self-reporting, meaning participants had to evaluate past altered states through the lens of their current psychological well-being. A person’s present mood can easily alter how past traumatic events or intimate encounters are remembered.
The comparison group in the study was also highly heterogeneous. This group likely included individuals who had never experienced sexual trauma alongside individuals who experienced trauma but did not find psychedelics useful. Combining these different experiences into a single control group obscures subtle trends in the data. The lack of standard definitions leaves room for vast variability in how people process their life histories.
The definition of sexual trauma was entirely determined by the participants, with no clinical verification or details regarding the severity of the past events. The survey question only asked if participants felt they had been helped by the substance, not if they took the drug with the strict intention of healing. Unmeasured variables like the context of the relationship, the specific type of drug consumed, and the dosage could have heavily influenced the outcomes.
Moving forward, researchers recommend conducting longitudinal studies that track individuals across extended periods. Observing these interpersonal shifts in a controlled clinical environment could clarify whether the emotional changes last beyond the immediate drug experience. Future studies could also formally standardize the measurement of psychedelic-induced intimacy to help build robust frameworks for those seeking alternative therapies for trauma.
The study, “Psychedelics and Sexual Trauma: Effects on Communication and Emotional Connection,” was authored by Mason Levey, Benjamin Bonenti, Timothy Piatkowski, Jason Ferris, Alex Frankovitch, Monica Barratt, Emma L. Davies, Adam Winstock, and Cheneal Puljević.
